{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T04:49:21Z","timestamp":1782967761499,"version":"3.54.5"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1038\/s41380-025-03036-7","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T01:05:39Z","timestamp":1746061539000},"page":"4512-4528","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["APOE deficiency inhibits amyloid-facilitated (A) tau pathology (T) and neurodegeneration (N), halting progressive ATN pathology in a preclinical model"],"prefix":"10.1038","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1594-5521","authenticated-orcid":false,"given":"Sarah","family":"Vanherle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9499-5680","authenticated-orcid":false,"given":"Art","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8545-1166","authenticated-orcid":false,"given":"Manuel","family":"Guti\u00e9rrez de Rav\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bieke","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chritica","family":"Lodder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Botella Lucena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0070-7482","authenticated-orcid":false,"given":"Sofie","family":"Kessels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7511-1782","authenticated-orcid":false,"given":"Jana","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eline","family":"Vandeput","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4271-0193","authenticated-orcid":false,"given":"Ilie-Cosmin","family":"Stancu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0981-9587","authenticated-orcid":false,"given":"Andrei","family":"Segal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Kleinewietfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Voets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert","family":"Br\u00f4ne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh","family":"Poovathingal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1959-5393","authenticated-orcid":false,"given":"Yeranddy A.","family":"Alpizar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7202-515X","authenticated-orcid":false,"given":"Ilse","family":"Dewachter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"key":"3036_CR1","unstructured":"Alzheimer\u2019s Disease International 2018. The state of the art of dementia research: new frontiers. World Alzheimer Report; London; 2018."},{"key":"3036_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.100982","volume":"4","author":"DS Knopman","year":"2023","unstructured":"Knopman DS. Lecanemab reduces brain amyloid-beta and delays cognitive worsening. Cell Rep Med. 2023;4:100982. https:\/\/doi.org\/10.1016\/j.xcrm.2023.100982.","journal-title":"Cell Rep Med"},{"key":"3036_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in early Alzheimer\u2019s disease. N Engl J Med. 2023;388:9\u201321. https:\/\/doi.org\/10.1056\/NEJMoa2212948.","journal-title":"N Engl J Med"},{"key":"3036_CR4","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jama.2023.13239","volume":"330","author":"JR Sims","year":"2023","unstructured":"Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks J, et al. Donanemab in early symptomatic Alzheimer disease: The TRAILBLAZER-ALZ 2 randomized clinical trial. JAMA. 2023;330:512\u201327. https:\/\/doi.org\/10.1001\/jama.2023.13239.","journal-title":"JAMA"},{"key":"3036_CR5","doi-asserted-by":"publisher","first-page":"4757","DOI":"10.1016\/j.cell.2023.09.023","volume":"186","author":"AL Boxer","year":"2023","unstructured":"Boxer AL, Sperling R. Accelerating Alzheimer\u2019s therapeutic development: the past and future of clinical trials. Cell. 2023;186:4757\u201372. https:\/\/doi.org\/10.1016\/j.cell.2023.09.023.","journal-title":"Cell"},{"key":"3036_CR6","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1016\/j.cell.2023.08.021","volume":"186","author":"M Jucker","year":"2023","unstructured":"Jucker M, Walker LC. Alzheimer\u2019s disease: from immunotherapy to immunoprevention. Cell. 2023;186:4260\u201370. https:\/\/doi.org\/10.1016\/j.cell.2023.08.021.","journal-title":"Cell"},{"key":"3036_CR7","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","volume":"186","author":"DM Wilson 3rd","year":"2023","unstructured":"Wilson DM 3rd, Cookson MR, Van Den Bosch L, Zetterberg H, Holtzman DM, Dewachter I. Hallmarks of neurodegenerative diseases. Cell. 2023;186:693\u2013714. https:\/\/doi.org\/10.1016\/j.cell.2022.12.032.","journal-title":"Cell"},{"key":"3036_CR8","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/bf00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82:239\u201359. https:\/\/doi.org\/10.1007\/bf00308809.","journal-title":"Acta Neuropathol"},{"key":"3036_CR9","doi-asserted-by":"publisher","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","volume":"1","author":"A Serrano-Pozo","year":"2011","unstructured":"Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT. Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med. 2011;1:a006189. https:\/\/doi.org\/10.1101\/cshperspect.a006189.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"3036_CR10","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/wnl.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal DR, Rub U, Orantes M, Braak H. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology. 2002;58:1791\u20131800. https:\/\/doi.org\/10.1212\/wnl.58.12.1791.","journal-title":"Neurology"},{"key":"3036_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","volume":"8","author":"BT Hyman","year":"2012","unstructured":"Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC, et al. National institute on aging-Alzheimer\u2019s association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease. Alzheimers Dement. 2012;8:1\u201313. https:\/\/doi.org\/10.1016\/j.jalz.2011.10.007.","journal-title":"Alzheimers Dement"},{"key":"3036_CR12","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr.","year":"2018","unstructured":"Jack CR Jr., Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14:535\u201362. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018.","journal-title":"Alzheimers Dement"},{"key":"3036_CR13","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1212\/wnl.0000000000002923","volume":"87","author":"CR Jack Jr.","year":"2016","unstructured":"Jack CR Jr., Bennett DA, Blennow K, Carrillo MC, Feldman HH, Frisoni GB, et al. A\/T\/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology. 2016;87:539\u201347. https:\/\/doi.org\/10.1212\/wnl.0000000000002923.","journal-title":"Neurology"},{"key":"3036_CR14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","volume":"12","author":"CR Jack Jr.","year":"2013","unstructured":"Jack CR Jr., Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, et al. Tracking pathophysiological processes in Alzheimer\u2019s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013;12:207\u201316. https:\/\/doi.org\/10.1016\/S1474-4422(12)70291-0.","journal-title":"Lancet Neurol"},{"key":"3036_CR15","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1001\/jamaneurol.2019.1424","volume":"76","author":"BJ Hanseeuw","year":"2019","unstructured":"Hanseeuw BJ, Betensky RA, Jacobs HIL, Schultz AP, Sepulcre J, Becker JA, et al. Association of amyloid and tau with cognition in preclinical Alzheimer disease: A longitudinal study. JAMA Neurol. 2019;76:915\u201324. https:\/\/doi.org\/10.1001\/jamaneurol.2019.1424.","journal-title":"JAMA Neurol"},{"key":"3036_CR16","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1202753","volume":"367","author":"RJ Bateman","year":"2012","unstructured":"Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, et al. Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease. N Engl J Med. 2012;367:795\u2013804. https:\/\/doi.org\/10.1056\/NEJMoa1202753.","journal-title":"N Engl J Med"},{"key":"3036_CR17","doi-asserted-by":"publisher","first-page":"3517","DOI":"10.1093\/brain\/awab248","volume":"144","author":"TA Pascoal","year":"2021","unstructured":"Pascoal TA, Benedet AL, Tudorascu DL, Therriault J, Mathotaarachchi S, Savard M, et al. Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages. Brain. 2021;144:3517\u201328. https:\/\/doi.org\/10.1093\/brain\/awab248.","journal-title":"Brain"},{"key":"3036_CR18","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1001\/jamaneurol.2016.5755","volume":"74","author":"C Xia","year":"2017","unstructured":"Xia C, Makaretz SJ, Caso C, McGinnis S, Gomperts SN, Sepulcre J, et al. Association of in vivo [18F]AV-1451 tau PET imaging results with cortical atrophy and symptoms in typical and atypical Alzheimer disease. JAMA Neurol. 2017;74:427\u201336. https:\/\/doi.org\/10.1001\/jamaneurol.2016.5755.","journal-title":"JAMA Neurol"},{"key":"3036_CR19","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science. 2002;297:353\u20136. https:\/\/doi.org\/10.1126\/science.1072994.","journal-title":"Science"},{"key":"3036_CR20","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"JM Long","year":"2019","unstructured":"Long JM, Holtzman DM. Alzheimer disease: an update on pathobiology and treatment strategies. Cell. 2019;179:312\u201339. https:\/\/doi.org\/10.1016\/j.cell.2019.09.001.","journal-title":"Cell"},{"key":"3036_CR21","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/nn.4018","volume":"18","author":"ES Musiek","year":"2015","unstructured":"Musiek ES, Holtzman DM. Three dimensions of the amyloid hypothesis: time, space and \u2018wingmen\u2019. Nat Neurosci. 2015;18:800\u20136. https:\/\/doi.org\/10.1038\/nn.4018.","journal-title":"Nat Neurosci"},{"key":"3036_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100636","volume":"3","author":"N Bhatt","year":"2022","unstructured":"Bhatt N, Kayed R. Quantification and targeting of elusive neurotoxic amyloid oligomers. Cell Rep Med. 2022;3:100636. https:\/\/doi.org\/10.1016\/j.xcrm.2022.100636.","journal-title":"Cell Rep Med"},{"key":"3036_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100630","volume":"3","author":"B Kass","year":"2022","unstructured":"Kass B, Schemmert S, Zafiu C, Pils M, Bannach O, Kutzsche J, et al. Abeta oligomer concentration in mouse and human brain and its drug-induced reduction ex vivo. Cell Rep Med. 2022;3:100630. https:\/\/doi.org\/10.1016\/j.xcrm.2022.100630.","journal-title":"Cell Rep Med"},{"key":"3036_CR24","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ebiom.2016.03.035","volume":"6","author":"U Sengupta","year":"2016","unstructured":"Sengupta U, Nilson AN, Kayed R. The role of amyloid-beta oligomers in toxicity, propagation, and immunotherapy. EBioMedicine. 2016;6:42\u20139. https:\/\/doi.org\/10.1016\/j.ebiom.2016.03.035.","journal-title":"EBioMedicine"},{"key":"3036_CR25","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1002\/pro.3499","volume":"27","author":"G Ghag","year":"2018","unstructured":"Ghag G, Bhatt N, Cantu DV, Guerrero-Munoz MJ, Ellsworth A, Sengupta U, et al. Soluble tau aggregates, not large fibrils, are the toxic species that display seeding and cross-seeding behavior. Protein Sci. 2018;27:1901\u20139. https:\/\/doi.org\/10.1002\/pro.3499.","journal-title":"Protein Sci"},{"key":"3036_CR26","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nature04533","volume":"440","author":"S Lesne","year":"2006","unstructured":"Lesne S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, et al. A specific amyloid-beta protein assembly in the brain impairs memory. Nature. 2006;440:352\u20137. https:\/\/doi.org\/10.1038\/nature04533.","journal-title":"Nature"},{"key":"3036_CR27","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1126\/science.1079469","volume":"300","author":"R Kayed","year":"2003","unstructured":"Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science. 2003;300:486\u20139. https:\/\/doi.org\/10.1126\/science.1079469.","journal-title":"Science"},{"key":"3036_CR28","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abc9375","volume":"13","author":"CC Liu","year":"2021","unstructured":"Liu CC, Murray ME, Li X, Zhao N, Wang N, Heckman MG, et al. APOE3-Jacksonville (V236E) variant reduces self-aggregation and risk of dementia. Sci Transl Med. 2021;13:eabc9375. https:\/\/doi.org\/10.1126\/scitranslmed.abc9375.","journal-title":"Sci Transl Med"},{"key":"3036_CR29","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1038\/s41591-019-0611-3","volume":"25","author":"JF Arboleda-Velasquez","year":"2019","unstructured":"Arboleda-Velasquez JF, Lopera F, O\u2019Hare M, Delgado-Tirado S, Marino C, Chmielewska N, et al. Resistance to autosomal dominant Alzheimer\u2019s disease in an APOE3 Christchurch homozygote: a case report. Nat Med. 2019;25:1680\u20133. https:\/\/doi.org\/10.1038\/s41591-019-0611-3.","journal-title":"Nat Med"},{"key":"3036_CR30","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1038\/s41591-019-0634-9","volume":"25","author":"KA Zalocusky","year":"2019","unstructured":"Zalocusky KA, Nelson MR, Huang Y. An Alzheimer\u2019s-disease-protective APOE mutation. Nat Med. 2019;25:1648\u20139. https:\/\/doi.org\/10.1038\/s41591-019-0634-9.","journal-title":"Nat Med"},{"key":"3036_CR31","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.cell.2023.11.029","volume":"187","author":"Y Chen","year":"2024","unstructured":"Chen Y, Song S, Parhizkar S, Lord J, Zhu Y, Strickland MR, et al. APOE3ch alters microglial response and suppresses Abeta-induced tau seeding and spread. Cell. 2024;187:428\u201345.e420. https:\/\/doi.org\/10.1016\/j.cell.2023.11.029.","journal-title":"Cell"},{"key":"3036_CR32","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1038\/s41591-023-02318-3","volume":"29","author":"F Lopera","year":"2023","unstructured":"Lopera F, Marino C, Chandrahas AS, O\u2019Hare M, Villalba-Moreno ND, Aguillon D, et al. Resilience to autosomal dominant Alzheimer\u2019s disease in a Reelin-COLBOS heterozygous man. Nat Med. 2023;29:1243\u201352. https:\/\/doi.org\/10.1038\/s41591-023-02318-3.","journal-title":"Nat Med"},{"key":"3036_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101111","volume":"4","author":"EN Mouofo","year":"2023","unstructured":"Mouofo EN, Spires-Jones TL. Reeling from news that reelin defends the brain against Alzheimer\u2019s. Cell Rep Med. 2023;4:101111. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101111.","journal-title":"Cell Rep Med"},{"key":"3036_CR34","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science. 1993;261:921\u20133. https:\/\/doi.org\/10.1126\/science.8346443.","journal-title":"Science"},{"key":"3036_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/1755-8794-1-44","volume":"1","author":"R Abraham","year":"2008","unstructured":"Abraham R, Moskvina V, Sims R, Hollingworth P, Morgan A, Georgieva L, et al. A genome-wide association study for late-onset Alzheimer\u2019s disease using DNA pooling. BMC Med Genomics. 2008;1:44. https:\/\/doi.org\/10.1186\/1755-8794-1-44.","journal-title":"BMC Med Genomics"},{"key":"3036_CR36","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/ng.440","volume":"41","author":"D Harold","year":"2009","unstructured":"Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease. Nat Genet. 2009;41:1088\u201393. https:\/\/doi.org\/10.1038\/ng.440.","journal-title":"Nat Genet"},{"key":"3036_CR37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13024-022-00516-0","volume":"17","author":"TE Mahan","year":"2022","unstructured":"Mahan TE, Wang C, Bao X, Choudhury A, Ulrich JD, Holtzman DM. Selective reduction of astrocyte apoE3 and apoE4 strongly reduces A\u03b2 accumulation and plaque-related pathology in a mouse model of amyloidosis. Mol Neurodegener. 2022;17:13. https:\/\/doi.org\/10.1186\/s13024-022-00516-0.","journal-title":"Mol Neurodegener"},{"key":"3036_CR38","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/s41591-024-02931-w","volume":"30","author":"J Fortea","year":"2024","unstructured":"Fortea J, Pegueroles J, Alcolea D, Belbin O, Dols-Icardo O, Vaque-Alcazar L, et al. APOE4 homozygozity represents a distinct genetic form of Alzheimer\u2019s disease. Nat Med. 2024;30:1284\u201391. https:\/\/doi.org\/10.1038\/s41591-024-02931-w.","journal-title":"Nat Med"},{"key":"3036_CR39","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.neuron.2017.11.013","volume":"96","author":"CC Liu","year":"2017","unstructured":"Liu CC, Zhao N, Fu Y, Wang N, Linares C, Tsai CW, et al. ApoE4 accelerates early seeding of amyloid pathology. Neuron. 2017;96:1024\u201332.e1023. https:\/\/doi.org\/10.1016\/j.neuron.2017.11.013.","journal-title":"Neuron"},{"key":"3036_CR40","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nature24016","volume":"549","author":"Y Shi","year":"2017","unstructured":"Shi Y, Yamada K, Liddelow SA, Smith ST, Zhao L, Luo W, et al. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature. 2017;549:523\u20137. https:\/\/doi.org\/10.1038\/nature24016.","journal-title":"Nature"},{"key":"3036_CR41","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/j.neuron.2021.03.024","volume":"109","author":"C Wang","year":"2021","unstructured":"Wang C, Xiong M, Gratuze M, Bao X, Shi Y, Andhey PS, et al. Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microglia. Neuron. 2021;109:1657\u201374.e1657. https:\/\/doi.org\/10.1016\/j.neuron.2021.03.024.","journal-title":"Neuron"},{"key":"3036_CR42","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00401-010-0666-1","volume":"119","author":"DZ Christensen","year":"2010","unstructured":"Christensen DZ, Schneider-Axmann T, Lucassen PJ, Bayer TA, Wirths O. Accumulation of intraneuronal Abeta correlates with ApoE4 genotype. Acta Neuropathol. 2010;119:555\u201366. https:\/\/doi.org\/10.1007\/s00401-010-0666-1.","journal-title":"Acta Neuropathol"},{"key":"3036_CR43","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/1531-8249(200006)47:6<739::AID-ANA6>3.0.CO;2-8","volume":"47","author":"DM Holtzman","year":"2000","unstructured":"Holtzman DM, Fagan AM, Mackey B, Tenkova T, Sartorius L, Paul SM, et al. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer\u2019s disease model. Ann Neurol. 2000;47:739\u201347.","journal-title":"Ann Neurol"},{"key":"3036_CR44","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1084\/jem.20171265","volume":"215","author":"JD Ulrich","year":"2018","unstructured":"Ulrich JD, Ulland TK, Mahan TE, Nystrom S, Nilsson KP, Song WM, et al. ApoE facilitates the microglial response to amyloid plaque pathology. J Exp Med. 2018;215:1047\u201358. https:\/\/doi.org\/10.1084\/jem.20171265.","journal-title":"J Exp Med"},{"key":"3036_CR45","doi-asserted-by":"publisher","DOI":"10.1172\/JCI169131","author":"C Wang","year":"2023","unstructured":"Wang C, Nambiar A, Strickland MR, Lee C, Parhizkar S, Moore AC, et al. APOE-epsilon4 synergizes with sleep disruption to accelerate Abeta deposition and Abeta-associated tau seeding and spreading. J Clin Invest. 2023. https:\/\/doi.org\/10.1172\/JCI169131.","journal-title":"J Clin Invest"},{"key":"3036_CR46","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1038\/s41593-023-01480-8","volume":"26","author":"MR Nelson","year":"2023","unstructured":"Nelson MR, Liu P, Agrawal A, Yip O, Blumenfeld J, Traglia M, et al. The APOE-R136S mutation protects against APOE4-driven tau pathology, neurodegeneration and neuroinflammation. Nat Neurosci. 2023;26:2104\u201321. https:\/\/doi.org\/10.1038\/s41593-023-01480-8.","journal-title":"Nat Neurosci"},{"key":"3036_CR47","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s40478-021-01204-8","volume":"9","author":"C Lodder","year":"2021","unstructured":"Lodder C, Scheyltjens I, Stancu IC, Botella Lucena P, Gutierrez de Rave M, Vanherle S, et al. CSF1R inhibition rescues tau pathology and neurodegeneration in an A\/T\/N model with combined AD pathologies, while preserving plaque associated microglia. Acta Neuropathol Commun. 2021;9:108. https:\/\/doi.org\/10.1186\/s40478-021-01204-8.","journal-title":"Acta Neuropathol Commun"},{"key":"3036_CR48","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J Neurosci. 2006;26:10129\u201340. https:\/\/doi.org\/10.1523\/JNEUROSCI.1202-06.2006.","journal-title":"J Neurosci"},{"key":"3036_CR49","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1096\/fj.13-246702","volume":"28","author":"IC Stancu","year":"2014","unstructured":"Stancu IC, Ris L, Vasconcelos B, Marinangeli C, Goeminne L, Laporte V, et al. Tauopathy contributes to synaptic and cognitive deficits in a murine model for Alzheimer\u2019s disease. FASEB J. 2014;28:2620\u201331. https:\/\/doi.org\/10.1096\/fj.13-246702.","journal-title":"FASEB J"},{"key":"3036_CR50","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","volume":"53","author":"Y Yoshiyama","year":"2007","unstructured":"Yoshiyama Y, Higuchi M, Zhang B, Huang SM, Iwata N, Saido TC, et al. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron. 2007;53:337\u201351. https:\/\/doi.org\/10.1016\/j.neuron.2007.01.010.","journal-title":"Neuron"},{"key":"3036_CR51","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40478-015-0199-x","volume":"3","author":"AM Pooler","year":"2015","unstructured":"Pooler AM, Polydoro M, Maury EA, Nicholls SB, Reddy SM, Wegmann S, et al. Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer\u2019s disease. Acta Neuropathol Commun. 2015;3:14. https:\/\/doi.org\/10.1186\/s40478-015-0199-x.","journal-title":"Acta Neuropathol Commun"},{"key":"3036_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12082","volume":"7","author":"T Li","year":"2016","unstructured":"Li T, Braunstein KE, Zhang J, Lau A, Sibener L, Deeble C, et al. The neuritic plaque facilitates pathological conversion of tau in an Alzheimer\u2019s disease mouse model. Nat Commun. 2016;7:12082. https:\/\/doi.org\/10.1038\/ncomms12082.","journal-title":"Nat Commun"},{"key":"3036_CR53","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/341162a0","volume":"341","author":"U Beisiegel","year":"1989","unstructured":"Beisiegel U, Weber W, Ihrke G, Herz J, Stanley KK. The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein. Nature. 1989;341:162\u20134. https:\/\/doi.org\/10.1038\/341162a0.","journal-title":"Nature"},{"key":"3036_CR54","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41586-020-2156-5","volume":"580","author":"JN Rauch","year":"2020","unstructured":"Rauch JN, Luna G, Guzman E, Audouard M, Challis C, Sibih YE, et al. LRP1 is a master regulator of tau uptake and spread. Nature. 2020;580:381\u20135. https:\/\/doi.org\/10.1038\/s41586-020-2156-5.","journal-title":"Nature"},{"key":"3036_CR55","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/s0896-6273(00)80861-2","volume":"24","author":"T Hiesberger","year":"1999","unstructured":"Hiesberger T, Trommsdorff M, Howell BW, Goffinet A, Mumby MC, Cooper JA, et al. Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation. Neuron. 1999;24:481\u20139. https:\/\/doi.org\/10.1016\/s0896-6273(00)80861-2.","journal-title":"Neuron"},{"key":"3036_CR56","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell. 2017;169:1276\u201390.e1217. https:\/\/doi.org\/10.1016\/j.cell.2017.05.018.","journal-title":"Cell"},{"key":"3036_CR57","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy R, et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity. 2017;47:566\u201381.e569. https:\/\/doi.org\/10.1016\/j.immuni.2017.08.008.","journal-title":"Immunity"},{"key":"3036_CR58","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1016\/j.neuron.2022.10.020","volume":"110","author":"RC Paolicelli","year":"2022","unstructured":"Paolicelli RC, Sierra A, Stevens B, Tremblay ME, Aguzzi A, Ajami B, et al. Microglia states and nomenclature: a field at its crossroads. Neuron. 2022;110:3458\u201383. https:\/\/doi.org\/10.1016\/j.neuron.2022.10.020.","journal-title":"Neuron"},{"key":"3036_CR59","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, et al. Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. 2015;14:388\u2013405. https:\/\/doi.org\/10.1016\/S1474-4422(15)70016-5.","journal-title":"Lancet Neurol"},{"key":"3036_CR60","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/ni.3102","volume":"16","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Golenbock DT, Latz E. Innate immunity in Alzheimer\u2019s disease. Nat Immunol. 2015;16:229\u201336. https:\/\/doi.org\/10.1038\/ni.3102.","journal-title":"Nat Immunol"},{"key":"3036_CR61","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1126\/science.aag2590","volume":"353","author":"RM Ransohoff","year":"2016","unstructured":"Ransohoff RM. How neuroinflammation contributes to neurodegeneration. Science. 2016;353:777\u201383. https:\/\/doi.org\/10.1126\/science.aag2590.","journal-title":"Science"},{"key":"3036_CR62","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/s41577-018-0051-1","volume":"18","author":"Y Shi","year":"2018","unstructured":"Shi Y, Holtzman DM. Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight. Nat Rev Immunol. 2018;18:759\u201372. https:\/\/doi.org\/10.1038\/s41577-018-0051-1.","journal-title":"Nat Rev Immunol"},{"key":"3036_CR63","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.neuron.2022.03.004","volume":"110","author":"YA Martens","year":"2022","unstructured":"Martens YA, Zhao N, Liu CC, Kanekiyo T, Yang AJ, Goate AM, et al. ApoE cascade hypothesis in the pathogenesis of Alzheimer\u2019s disease and related dementias. Neuron. 2022;110:1304\u201317. https:\/\/doi.org\/10.1016\/j.neuron.2022.03.004.","journal-title":"Neuron"},{"key":"3036_CR64","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.neuron.2020.10.008","volume":"109","author":"Y Chen","year":"2021","unstructured":"Chen Y, Strickland MR, Soranno A, Holtzman DM. Apolipoprotein E: structural insights and links to Alzheimer disease pathogenesis. Neuron. 2021;109:205\u201321. https:\/\/doi.org\/10.1016\/j.neuron.2020.10.008.","journal-title":"Neuron"},{"key":"3036_CR65","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13024-022-00566-4","volume":"17","author":"R Fernandez-Calle","year":"2022","unstructured":"Fernandez-Calle R, Konings SC, Frontinan-Rubio J, Garcia-Revilla J, Camprubi-Ferrer L, Svensson M, et al. APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer\u2019s disease pathology and brain diseases. Mol Neurodegener. 2022;17:62 https:\/\/doi.org\/10.1186\/s13024-022-00566-4.","journal-title":"Mol Neurodegener"},{"key":"3036_CR66","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1159\/000322228","volume":"8","author":"A Bellucci","year":"2011","unstructured":"Bellucci A, Bugiani O, Ghetti B, Spillantini MG. Presence of reactive microglia and neuroinflammatory mediators in a case of frontotemporal dementia with P301S mutation. Neurodegener Dis. 2011;8:221\u20139. https:\/\/doi.org\/10.1159\/000322228.","journal-title":"Neurodegener Dis"},{"key":"3036_CR67","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/S0002-9440(10)63421-9","volume":"165","author":"A Bellucci","year":"2004","unstructured":"Bellucci A, Westwood AJ, Ingram E, Casamenti F, Goedert M, Spillantini MG. Induction of inflammatory mediators and microglial activation in mice transgenic for mutant human P301S tau protein. Am J Pathol. 2004;165:1643\u201352. https:\/\/doi.org\/10.1016\/S0002-9440(10)63421-9.","journal-title":"Am J Pathol"},{"key":"3036_CR68","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1093\/brain\/awaa033","volume":"143","author":"WR Bevan-Jones","year":"2020","unstructured":"Bevan-Jones WR, Cope TE, Jones PS, Kaalund SS, Passamonti L, Allinson K, et al. Neuroinflammation and protein aggregation co-localize across the frontotemporal dementia spectrum. Brain. 2020;143:1010\u201326. https:\/\/doi.org\/10.1093\/brain\/awaa033.","journal-title":"Brain"},{"key":"3036_CR69","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1093\/brain\/awy188","volume":"141","author":"M Dani","year":"2018","unstructured":"Dani M, Wood M, Mizoguchi R, Fan Z, Walker Z, Morgan R, et al. Microglial activation correlates in vivo with both tau and amyloid in Alzheimer\u2019s disease. Brain. 2018;141:2740\u201354. https:\/\/doi.org\/10.1093\/brain\/awy188.","journal-title":"Brain"},{"key":"3036_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-01820-6","volume":"17","author":"R Ismail","year":"2020","unstructured":"Ismail R, Parbo P, Madsen LS, Hansen AK, Hansen KV, Schaldemose JL, et al. The relationships between neuroinflammation, beta-amyloid and tau deposition in Alzheimer\u2019s disease: a longitudinal PET study. J Neuroinflammation. 2020;17:151. https:\/\/doi.org\/10.1186\/s12974-020-01820-6.","journal-title":"J Neuroinflammation"},{"key":"3036_CR71","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1038\/s41591-021-01456-w","volume":"27","author":"TA Pascoal","year":"2021","unstructured":"Pascoal TA, Benedet AL, Ashton NJ, Kang MS, Therriault J, Chamoun M, et al. Microglial activation and tau propagate jointly across Braak stages. Nat Med. 2021;27:1592\u20139. https:\/\/doi.org\/10.1038\/s41591-021-01456-w.","journal-title":"Nat Med"},{"key":"3036_CR72","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1084\/jem.20190980","volume":"216","author":"Y Shi","year":"2019","unstructured":"Shi Y, Manis M, Long J, Wang K, Sullivan PM, Remolina Serrano J, et al. Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model. J Exp Med. 2019;216:2546\u201361. https:\/\/doi.org\/10.1084\/jem.20190980.","journal-title":"J Exp Med"},{"key":"3036_CR73","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00401-018-01957-y","volume":"137","author":"IC Stancu","year":"2019","unstructured":"Stancu IC, Cremers N, Vanrusselt H, Couturier J, Vanoosthuyse A, Kessels S, et al. Aggregated tau activates NLRP3-ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded tau pathology in vivo. Acta Neuropathol. 2019;137:599\u2013617. https:\/\/doi.org\/10.1007\/s00401-018-01957-y.","journal-title":"Acta Neuropathol"},{"key":"3036_CR74","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","volume":"575","author":"C Ising","year":"2019","unstructured":"Ising C, Venegas C, Zhang S, Scheiblich H, Schmidt SV, Vieira-Saecker A, et al. NLRP3 inflammasome activation drives tau pathology. Nature. 2019;575:669\u201373. https:\/\/doi.org\/10.1038\/s41586-019-1769-z.","journal-title":"Nature"},{"key":"3036_CR75","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1093\/brain\/awz241","volume":"142","author":"R Mancuso","year":"2019","unstructured":"Mancuso R, Fryatt G, Cleal M, Obst J, Pipi E, Monzon-Sandoval J, et al. CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice. Brain. 2019;142:3243\u201364. https:\/\/doi.org\/10.1093\/brain\/awz241.","journal-title":"Brain"},{"key":"3036_CR76","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1084\/jem.20180653","volume":"215","author":"SS Kang","year":"2018","unstructured":"Kang SS, Ebbert MTW, Baker KE, Cook C, Wang X, Sens JP, et al. Microglial translational profiling reveals a convergent APOE pathway from aging, amyloid, and tau. J Exp Med. 2018;215:2235\u201345. https:\/\/doi.org\/10.1084\/jem.20180653.","journal-title":"J Exp Med"},{"key":"3036_CR77","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/s41593-019-0393-4","volume":"22","author":"H Van Hove","year":"2019","unstructured":"Van Hove H, Martens L, Scheyltjens I, De Vlaminck K, Pombo Antunes AR, De Prijck S, et al. A single-cell atlas of mouse brain macrophages reveals unique transcriptional identities shaped by ontogeny and tissue environment. Nat Neurosci. 2019;22:1021\u201335. https:\/\/doi.org\/10.1038\/s41593-019-0393-4.","journal-title":"Nat Neurosci"},{"key":"3036_CR78","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, et al. Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing. Nat Genet. 2019;51:414\u201330. https:\/\/doi.org\/10.1038\/s41588-019-0358-2.","journal-title":"Nat Genet"},{"key":"3036_CR79","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41593-020-0599-5","volume":"23","author":"R Sims","year":"2020","unstructured":"Sims R, Hill M, Williams J. The multiplex model of the genetics of Alzheimer\u2019s disease. Nat Neurosci. 2020;23:311\u201322. https:\/\/doi.org\/10.1038\/s41593-020-0599-5.","journal-title":"Nat Neurosci"},{"key":"3036_CR80","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00401-022-02458-9","volume":"144","author":"P Botella Lucena","year":"2022","unstructured":"Botella Lucena P, Vanherle S, Lodder C, Gutierrez de Rave M, Stancu IC, Lambrichts I, et al. Blood-based Abeta42 increases in the earliest pre-pathological stage before decreasing with progressive amyloid pathology in preclinical models and human subjects: opening new avenues for prevention. Acta Neuropathol. 2022;144:489\u2013508. https:\/\/doi.org\/10.1007\/s00401-022-02458-9.","journal-title":"Acta Neuropathol"},{"key":"3036_CR81","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.neuron.2018.01.022","volume":"97","author":"J McInnes","year":"2018","unstructured":"McInnes J, Wierda K, Snellinx A, Bounti L, Wang YC, Stancu IC, et al. Synaptogyrin-3 mediates presynaptic dysfunction induced by tau. Neuron. 2018;97:823\u201335.e828. https:\/\/doi.org\/10.1016\/j.neuron.2018.01.022.","journal-title":"Neuron"},{"key":"3036_CR82","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00401-015-1525-x","volume":"131","author":"B Vasconcelos","year":"2016","unstructured":"Vasconcelos B, Stancu IC, Buist A, Bird M, Wang P, Vanoosthuyse A, et al. Heterotypic seeding of tau fibrillization by pre-aggregated Abeta provides potent seeds for prion-like seeding and propagation of tau-pathology in vivo. Acta Neuropathol. 2016;131:549\u201369. https:\/\/doi.org\/10.1007\/s00401-015-1525-x.","journal-title":"Acta Neuropathol"},{"key":"3036_CR83","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s00401-016-1663-9","volume":"133","author":"P Wang","year":"2017","unstructured":"Wang P, Joberty G, Buist A, Vanoosthuyse A, Stancu IC, Vasconcelos B, et al. Tau interactome mapping based identification of Otub1 as tau deubiquitinase involved in accumulation of pathological Tau forms in vitro and in vivo. Acta Neuropathol. 2017;133:731\u201349. https:\/\/doi.org\/10.1007\/s00401-016-1663-9.","journal-title":"Acta Neuropathol"},{"key":"3036_CR84","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1523\/JNEUROSCI.4922-11.2012","volume":"32","author":"B Zhang","year":"2012","unstructured":"Zhang B, Carroll J, Trojanowski JQ, Yao Y, Iba M, Potuzak JS, et al. The microtubule-stabilizing agent, epothilone D, reduces axonal dysfunction, neurotoxicity, cognitive deficits, and Alzheimer-like pathology in an interventional study with aged tau transgenic mice. J Neurosci. 2012;32:3601\u201311. https:\/\/doi.org\/10.1523\/JNEUROSCI.4922-11.2012.","journal-title":"J Neurosci"},{"key":"3036_CR85","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1523\/JNEUROSCI.2642-12.2013","volume":"33","author":"M Iba","year":"2013","unstructured":"Iba M, Guo JL, McBride JD, Zhang B, Trojanowski JQ, Lee VM. Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer\u2019s-like tauopathy. J Neurosci. 2013;33:1024\u201337. https:\/\/doi.org\/10.1523\/JNEUROSCI.2642-12.2013.","journal-title":"J Neurosci"},{"key":"3036_CR86","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1750-3639.2007.00051.x","volume":"17","author":"J Gotz","year":"2007","unstructured":"Gotz J, Deters N, Doldissen A, Bokhari L, Ke Y, Wiesner A, et al. A decade of tau transgenic animal models and beyond. Brain Pathol. 2007;17:91\u2013103. https:\/\/doi.org\/10.1111\/j.1750-3639.2007.00051.x.","journal-title":"Brain Pathol"},{"key":"3036_CR87","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.3233\/JAD-132477","volume":"40","author":"DL Castillo-Carranza","year":"2014","unstructured":"Castillo-Carranza DL, Gerson JE, Sengupta U, Guerrero-Munoz MJ, Lasagna-Reeves CA, Kayed R. Specific targeting of tau oligomers in Htau mice prevents cognitive impairment and tau toxicity following injection with brain-derived tau oligomeric seeds. J Alzheimers Dis. 2014;40:S97\u2013S111. https:\/\/doi.org\/10.3233\/JAD-132477.","journal-title":"J Alzheimers Dis"},{"key":"3036_CR88","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s40478-021-01259-7","volume":"9","author":"CM Soto-Faguas","year":"2021","unstructured":"Soto-Faguas CM, Sanchez-Molina P, Saura CA. Loss of presenilin function enhances tau phosphorylation and aggregation in mice. Acta Neuropathol Commun. 2021;9:162. https:\/\/doi.org\/10.1186\/s40478-021-01259-7.","journal-title":"Acta Neuropathol Commun"},{"key":"3036_CR89","doi-asserted-by":"publisher","first-page":"786","DOI":"10.2353\/ajpath.2008.070904","volume":"172","author":"D Terwel","year":"2008","unstructured":"Terwel D, Muyllaert D, Dewachter I, Borghgraef P, Croes S, Devijver H, et al. Amyloid activates GSK-3beta to aggravate neuronal tauopathy in bigenic mice. Am J Pathol. 2008;172:786\u201398. https:\/\/doi.org\/10.2353\/ajpath.2008.070904.","journal-title":"Am J Pathol"},{"key":"3036_CR90","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s00401-015-1413-4","volume":"129","author":"IC Stancu","year":"2015","unstructured":"Stancu IC, Vasconcelos B, Ris L, Wang P, Villers A, Peeraer E, et al. Templated misfolding of tau by prion-like seeding along neuronal connections impairs neuronal network function and associated behavioral outcomes in tau transgenic mice. Acta Neuropathol. 2015;129:875\u201394. https:\/\/doi.org\/10.1007\/s00401-015-1413-4.","journal-title":"Acta Neuropathol"},{"key":"3036_CR91","doi-asserted-by":"publisher","first-page":"3963","DOI":"10.1074\/jbc.M409876200","volume":"280","author":"D Terwel","year":"2005","unstructured":"Terwel D, Lasrado R, Snauwaert J, Vandeweert E, Van Haesendonck C, Borghgraef P, et al. Changed conformation of mutant tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of tau-4R\/2N transgenic mice. J Biol Chem. 2005;280:3963\u201373. https:\/\/doi.org\/10.1074\/jbc.M409876200.","journal-title":"J Biol Chem"},{"key":"3036_CR92","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.neuron.2017.09.026","volume":"96","author":"YE Wu","year":"2017","unstructured":"Wu YE, Pan L, Zuo Y, Li X, Hong W. Detecting activated cell populations using single-cell RNA-seq. Neuron. 2017;96:313\u201329.e316. https:\/\/doi.org\/10.1016\/j.neuron.2017.09.026.","journal-title":"Neuron"},{"key":"3036_CR93","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.12688\/f1000research.9501.2","volume":"5","author":"AT Lun","year":"2016","unstructured":"Lun AT, McCarthy DJ, Marioni JC. A step-by-step workflow for low-level analysis of single-cell RNA-seq data with bioconductor. F1000Res. 2016;5:2122. https:\/\/doi.org\/10.12688\/f1000research.9501.2.","journal-title":"F1000Res"},{"key":"3036_CR94","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.2353\/ajpath.2007.070403","volume":"171","author":"T Bolmont","year":"2007","unstructured":"Bolmont T, Clavaguera F, Meyer-Luehmann M, Herzig MC, Radde R, Staufenbiel M, et al. Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x tau transgenic mice. Am J Pathol. 2007;171:2012\u201320. https:\/\/doi.org\/10.2353\/ajpath.2007.070403.","journal-title":"Am J Pathol"},{"key":"3036_CR95","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1126\/science.1062097","volume":"293","author":"J Gotz","year":"2001","unstructured":"Gotz J, Chen F, van Dorpe J, Nitsch RM. Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science. 2001;293:1491\u20135. https:\/\/doi.org\/10.1126\/science.1062097.","journal-title":"Science"},{"key":"3036_CR96","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.2353\/ajpath.2010.100346","volume":"177","author":"DE Hurtado","year":"2010","unstructured":"Hurtado DE, Molina-Porcel L, Iba M, Aboagye AK, Paul SM, Trojanowski JQ, et al. Abeta accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model. Am J Pathol. 2010;177:1977\u201388. https:\/\/doi.org\/10.2353\/ajpath.2010.100346.","journal-title":"Am J Pathol"},{"key":"3036_CR97","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1126\/science.1058189","volume":"293","author":"J Lewis","year":"2001","unstructured":"Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G, et al. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science. 2001;293:1487\u201391. https:\/\/doi.org\/10.1126\/science.1058189.","journal-title":"Science"},{"key":"3036_CR98","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1750-1326-9-51","volume":"9","author":"IC Stancu","year":"2014","unstructured":"Stancu IC, Vasconcelos B, Terwel D, Dewachter I. Models of beta-amyloid induced tau-pathology: the long and \u201cfolded\u201d road to understand the mechanism. Mol Neurodegener. 2014;9:51. https:\/\/doi.org\/10.1186\/1750-1326-9-51.","journal-title":"Mol Neurodegener"},{"key":"3036_CR99","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3389\/fnins.2015.00184","volume":"9","author":"J Brelstaff","year":"2015","unstructured":"Brelstaff J, Ossola B, Neher JJ, Klingstedt T, Nilsson KP, Goedert M, et al. The fluorescent pentameric oligothiophene pFTAA identifies filamentous tau in live neurons cultured from adult P301S tau mice. Front Neurosci. 2015;9:184 https:\/\/doi.org\/10.3389\/fnins.2015.00184.","journal-title":"Front Neurosci"},{"key":"3036_CR100","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13024-021-00458-z","volume":"16","author":"H Ben-Yehuda","year":"2021","unstructured":"Ben-Yehuda H, Arad M, Peralta Ramos JM, Sharon E, Castellani G, Ferrera S, et al. Key role of the CCR2-CCL2 axis in disease modification in a mouse model of tauopathy. Mol Neurodegener. 2021;16:39. https:\/\/doi.org\/10.1186\/s13024-021-00458-z.","journal-title":"Mol Neurodegener"},{"key":"3036_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111580","volume":"41","author":"LEL Romano","year":"2022","unstructured":"Romano LEL, Aw WY, Hixson KM, Novoselova TV, Havener TM, Howell S, et al. Multi-omic profiling reveals the ataxia protein sacsin is required for integrin trafficking and synaptic organization. Cell Rep. 2022;41:111580. https:\/\/doi.org\/10.1016\/j.celrep.2022.111580.","journal-title":"Cell Rep"},{"key":"3036_CR102","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/glia.24160","volume":"70","author":"IC Stancu","year":"2022","unstructured":"Stancu IC, Lodder C, Botella Lucena P, Vanherle S, Gutierrez de Rave M, Terwel D, et al. The NLRP3 inflammasome modulates tau pathology and neurodegeneration in a tauopathy model. Glia. 2022;70:1117\u201332. https:\/\/doi.org\/10.1002\/glia.24160.","journal-title":"Glia"},{"key":"3036_CR103","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1073\/pnas.050004797","volume":"97","author":"DM Holtzman","year":"2000","unstructured":"Holtzman DM, Bales KR, Tenkova T, Fagan AM, Parsadanian M, Sartorius LJ, et al. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci USA. 2000;97:2892\u20137. https:\/\/doi.org\/10.1073\/pnas.050004797.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3036_CR104","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"CC Liu","year":"2013","unstructured":"Liu CC, Liu CC, Kanekiyo T, Xu H, Bu G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol. 2013;9:106\u201318. https:\/\/doi.org\/10.1038\/nrneurol.2012.263.","journal-title":"Nat Rev Neurol"},{"key":"3036_CR105","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nm.4443","volume":"24","author":"Z He","year":"2018","unstructured":"He Z, Guo JL, McBride JD, Narasimhan S, Kim H, Changolkar L, et al. Amyloid-beta plaques enhance Alzheimer\u2019s brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation. Nat Med. 2018;24:29\u201338. https:\/\/doi.org\/10.1038\/nm.4443.","journal-title":"Nat Med"},{"key":"3036_CR106","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00401-018-1953-5","volume":"137","author":"C Vergara","year":"2019","unstructured":"Vergara C, Houben S, Suain V, Yilmaz Z, De Decker R, Vanden Dries V, et al. Amyloid-beta pathology enhances pathological fibrillary tau seeding induced by Alzheimer PHF in vivo. Acta Neuropathol. 2019;137:397\u2013412. https:\/\/doi.org\/10.1007\/s00401-018-1953-5.","journal-title":"Acta Neuropathol"},{"key":"3036_CR107","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.neuron.2014.01.045","volume":"81","author":"T Kanekiyo","year":"2014","unstructured":"Kanekiyo T, Xu H, Bu G. ApoE and Abeta in Alzheimer\u2019s disease: accidental encounters or partners? Neuron. 2014;81:740\u201354. https:\/\/doi.org\/10.1016\/j.neuron.2014.01.045.","journal-title":"Neuron"},{"key":"3036_CR108","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.neuron.2017.11.014","volume":"96","author":"TV Huynh","year":"2017","unstructured":"Huynh TV, Liao F, Francis CM, Robinson GO, Serrano JR, Jiang H, et al. Age-dependent effects of apoE reduction using antisense oligonucleotides in a model of beta-amyloidosis. Neuron. 2017;96:1013\u201323.e1014. https:\/\/doi.org\/10.1016\/j.neuron.2017.11.014.","journal-title":"Neuron"},{"key":"3036_CR109","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/jnc.12484","volume":"128","author":"S Liu","year":"2014","unstructured":"Liu S, Breitbart A, Sun Y, Mehta PD, Boutajangout A, Scholtzova H, et al. Blocking the apolipoprotein E\/amyloid beta interaction in triple transgenic mice ameliorates Alzheimer\u2019s disease related amyloid beta and tau pathology. J Neurochem. 2014;128:577\u201391. https:\/\/doi.org\/10.1111\/jnc.12484.","journal-title":"J Neurochem"},{"key":"3036_CR110","doi-asserted-by":"publisher","first-page":"e54083","DOI":"10.7554\/eLife.54083","volume":"9","author":"L Sebastian Monasor","year":"2020","unstructured":"Sebastian Monasor L, Muller SA, Colombo AV, Tanrioever G, Konig J, Roth S, et al. Fibrillar Abeta triggers microglial proteome alterations and dysfunction in Alzheimer mouse models. Elife. 2020;9:e54083 https:\/\/doi.org\/10.7554\/eLife.54083.","journal-title":"Elife"},{"key":"3036_CR111","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"MA DeTure","year":"2019","unstructured":"DeTure MA, Dickson DW. The neuropathological diagnosis of Alzheimer\u2019s disease. Mol Neurodegener. 2019;14:32 https:\/\/doi.org\/10.1186\/s13024-019-0333-5.","journal-title":"Mol Neurodegener"},{"key":"3036_CR112","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.3233\/JAD-160365","volume":"53","author":"M Malek-Ahmadi","year":"2016","unstructured":"Malek-Ahmadi M, Perez SE, Chen K, Mufson EJ. Neuritic and diffuse plaque associations with memory in non-cognitively impaired elderly. J Alzheimers Dis. 2016;53:1641\u201352. https:\/\/doi.org\/10.3233\/JAD-160365.","journal-title":"J Alzheimers Dis"},{"key":"3036_CR113","doi-asserted-by":"publisher","first-page":"5274","DOI":"10.1073\/pnas.96.9.5274","volume":"96","author":"RB Knowles","year":"1999","unstructured":"Knowles RB, Wyart C, Buldyrev SV, Cruz L, Urbanc B, Hasselmo ME, et al. Plaque-induced neurite abnormalities: implications for disruption of neural networks in Alzheimer\u2019s disease. Proc Natl Acad Sci USA. 1999;96:5274\u20139. https:\/\/doi.org\/10.1073\/pnas.96.9.5274.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3036_CR114","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1146\/annurev.genom.1.1.507","volume":"1","author":"RW Mahley","year":"2000","unstructured":"Mahley RW, Rall SC Jr. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet. 2000;1:507\u201337. https:\/\/doi.org\/10.1146\/annurev.genom.1.1.507.","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"3036_CR115","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11674-z","volume":"10","author":"E Spangenberg","year":"2019","unstructured":"Spangenberg E, Severson PL, Hohsfield LA, Crapser J, Zhang J, Burton EA, et al. Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer\u2019s disease model. Nat Commun. 2019;10:3758. https:\/\/doi.org\/10.1038\/s41467-019-11674-z.","journal-title":"Nat Commun"},{"key":"3036_CR116","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1348-5","volume":"15","author":"RE Bennett","year":"2018","unstructured":"Bennett RE, Bryant A, Hu M, Robbins AB, Hopp SC, Hyman BT. Partial reduction of microglia does not affect tau pathology in aged mice. J Neuroinflammation. 2018;15:311 https:\/\/doi.org\/10.1186\/s12974-018-1348-5.","journal-title":"J Neuroinflammation"},{"key":"3036_CR117","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.neuron.2009.06.026","volume":"63","author":"J Kim","year":"2009","unstructured":"Kim J, Basak JM, Holtzman DM. The role of apolipoprotein E in Alzheimer\u2019s disease. Neuron. 2009;63:287\u2013303. https:\/\/doi.org\/10.1016\/j.neuron.2009.06.026.","journal-title":"Neuron"},{"key":"3036_CR118","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1002\/ana.26351","volume":"91","author":"M Gratuze","year":"2022","unstructured":"Gratuze M, Jiang H, Wang C, Xiong M, Bao X, Holtzman DM. APOE antibody inhibits abeta-associated tau seeding and spreading in a mouse model. Ann Neurol. 2022;91:847\u201352. https:\/\/doi.org\/10.1002\/ana.26351.","journal-title":"Ann Neurol"},{"key":"3036_CR119","doi-asserted-by":"publisher","first-page":"eabd7522","DOI":"10.1126\/scitranslmed.abd7522","volume":"13","author":"M Xiong","year":"2021","unstructured":"Xiong M, Jiang H, Serrano JR, Gonzales ER, Wang C, Gratuze M, et al. APOE immunotherapy reduces cerebral amyloid angiopathy and amyloid plaques while improving cerebrovascular function. Sci Transl Med. 2021;13:eabd7522. https:\/\/doi.org\/10.1126\/scitranslmed.abd7522.","journal-title":"Sci Transl Med"},{"key":"3036_CR120","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1172\/JCI96429","volume":"128","author":"F Liao","year":"2018","unstructured":"Liao F, Li A, Xiong M, Bien-Ly N, Jiang H, Zhang Y, et al. Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation. J Clin Invest. 2018;128:2144\u201355. https:\/\/doi.org\/10.1172\/JCI96429.","journal-title":"J Clin Invest"},{"key":"3036_CR121","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nature12481","volume":"501","author":"M Jucker","year":"2013","unstructured":"Jucker M, Walker LC. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature. 2013;501:45\u201351. https:\/\/doi.org\/10.1038\/nature12481.","journal-title":"Nature"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03036-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03036-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03036-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T15:41:33Z","timestamp":1757950893000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03036-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":121,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["3036"],"URL":"https:\/\/doi.org\/10.1038\/s41380-025-03036-7","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,30]]},"assertion":[{"value":"3 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The ethical committee for animal welfare of Hasselt University approved all the performed experiments. All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}